Richard N. Kender - Jun 20, 2024 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGA)

Role
Director
Signature
/s/ Barbara Chan as Attorney-in-Fact for Richard N. Kender
Stock symbol
OMGA
Transactions as of
Jun 20, 2024
Transactions value $
$0
Form type
4
Date filed
6/21/2024, 04:20 PM
Previous filing
May 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Stock Option (Right to Buy) Award $0 +50K $0.00 50K Jun 20, 2024 Common Stock 50K $2.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in thirty-six substantially equal monthly installments following the date of grant, such that the option shall be fully vested and exercisable on the third anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such vesting date.